The Latest Breaking News from Covid-19

The U.S. Food and Drug Administration (FDA) has approved Bluebird bio’s (NASDAQ:BLUE) lead asset ZYNTEGLO (betibeglogene autotemcel) to treat the underlying genetic cause of beta‑thalassemia in adult and pediatric patients who require regular red blood cell (RBC) transfusions. Bluebird shares traded in a range of $6.13 to $8.18 on a day…

Study finds that unlike anxiety and depression, conditions including brain fog, dementia and psychosis, are still more likely two years on

As Christchurch Airport looks to spread its wings with a new international terminal in the wide open spaces of Tarras, Central Otago, the project’s leader explains its ambitions.

The Joint Committee on Vaccination and Immunisation has confirmed which vaccines are appropriate for the autumn booster following the new dual variant vaccine that targets Omicron and original variant.

Airlines have to ensure that passengers are wearing face masks properly throughout the journey and there is proper sensitisation of passengers through various platforms, according the the DCGA

India today is double dosing every citizen and produced COVID-19 vaccines even during the lockdown period, said Union Finance Minister Nirmala Sitharaman

Kelsey Ellison had waited years for a chance to see her idol perform so her partner captured her 'over-the-top' experience

New data shows Aussies are coming down with a serious case of travel fever, with international departures inching closer to pre-pandemic levels.

Brazil and Argentina agreed to pay a fine for not playing the qualifier, which was stopped shortly after kickoff when health officials entered the field saying four Argentina players had broken COVID-19 protocols